PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland.\', \'Division of Laboratory Medicine, Department of Diagnostics, Geneva University Hospitals and Geneva University, 1205 Geneva, Switzerland.\', \'Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, 1205 Geneva, Switzerland.\', \'Laboratory of Virology, Division of Laboratory Medicine, Geneva University Hospitals and Faculty of Medicine, 1205 Geneva, Switzerland.\', \'Center for Emerging Viral Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, 1205 Geneva, Switzerland.\', \'Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals and Faculty of Medicine, 1205 Geneva, Switzerland; sebastian.maerkl@epfl.ch Benjamin.Meyer@unige.ch isabella.eckerle@chuge.ch.\', \'Centre for Vaccinology, Department of Pathology and Immunology, University of Geneva, 1205 Geneva, Switzerland sebastian.maerkl@epfl.ch Benjamin.Meyer@unige.ch isabella.eckerle@chuge.ch.\', \'Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, 1015 Lausanne, Switzerland; sebastian.maerkl@epfl.ch Benjamin.Meyer@unige.ch isabella.eckerle@chuge.ch.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • e202528911810.1073/pnas.2025289118
?:hasPublicationType
?:journal
  • Proceedings of the National Academy of Sciences of the United States of America
is ?:pmid of
?:pmid
?:pmid
  • 33945500
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 6.092
?:rankingScore_hIndex
  • 675
?:title
  • A high-throughput microfluidic nanoimmunoassay for detecting anti-SARS-CoV-2 antibodies in serum or ultralow-volume blood samples.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33945500>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33945500>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all